Your observation makes total sense—if a vaccine's protection goes down over time, it feels completely logical that you would need a booster or an annual shot to stay safe.
The reason federal health agencies like the CDC currently advise only a single lifetime dose comes down to a few specific scientific factors:
- The protection is still strong enough to save lives: Even though the vaccine's power wanes over time, it continues to work against what matters most: severe illness and hospitalization. Research shows that a single shot reduces the risk of RSV hospitalization by about 69% in the first year and still provides roughly 48% protection in the second year. For an older or vulnerable adult, that lingering protection is still considered highly valuable.
- Boosters haven't shown a huge extra benefit yet: In clinical trials where researchers tested giving people a second "booster" dose of the RSV vaccine, the results showed that the booster didn't significantly jump-start or increase immunity compared to what a single dose was already doing over multiple seasons.
- Careful monitoring of rare side effects: Because the RSV vaccines are relatively new, health authorities are balancing the benefits with safety data. Scientists are closely watching very rare safety signals—such as a tiny, slight increase in cases of a nerve condition called Guillain-Barré syndrome. Until they are certain that a booster dose provides clear, necessary benefits that outweigh any potential risks, they are holding off on recommending repeat doses.
In short, scientists fully expect they might recommend an RSV booster in the future once they figure out the exact timeline of when it's truly necessary and safe. But for now, they are prioritizing a single shot because it gives heavy, multi-year protection right out of the gate.
I received a RSV shot in the fall of 2025.
